LONDON, England, Sept. 18 (TNSjou) -- BMJ Group issued the following news release about The BMJ:

* * *

GLP-1 and SGLT-2 diabetes drugs may help slow kidney damage

But little evidence of benefit seen among people without albuminuria

-

The diabetes drugs glucagon-like peptide-1 (GLP-1) receptor agonists and sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs may also help to slow decline in kidney function in people with type 2 d . . .

Click here for more information about our products